Early detection and continuous care have become essential in managing schizophrenia and psychotic disorders, which often emerge during adolescence or early adulthood. Recent advances highlight the importance of coordinated specialty care, combining antipsychotic medication, social support, and cognitive behavioral therapy. Neuroimaging and genetic studies continue to uncover biomarkers linked to psychotic symptoms, improving diagnostic accuracy. Innovations such as digital monitoring tools and long-acting injectable medications enhance treatment adherence and functional outcomes. Psychosocial rehabilitation remains a cornerstone, helping individuals build life skills, re-enter the workforce, and maintain meaningful relationships. Integrating neuroscience, clinical care, and social services offers a more holistic approach to sustained recovery.
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Gangstalking is real, should be studied
Sam Vaknin, Southern Federal University, United Kingdom
Title : Decoding aggression, violence, and substance use in adolescents with conduct disorders: Neurochemical pathways and interventions
Ann Marie Leonard Zabel, Curry College, United States
Title : Sensoria driven genetic decoupling and impaired areal integration in diseases of agency
Denis Larrivee, University of Navarra, Spain
Title : Positive outcome of adherence to the reward deficiency syndrome solution system treatment plan: A longitudinal study
Elizabeth Dale Gilley, The Elle Foundation, United States